Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

AMT may be more effective than finasteride for hair growth in androgenetic alopecia.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Abnormal amino acid metabolism may worsen rosacea symptoms.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Higher HDAC1 levels in alopecia areata suggest HDAC inhibitors might help treat it and acne.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Alopecia Areata may involve reduced antioxidant defenses in hair follicles, affecting stem cell function.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Allopregnanolone changes gene expression in glioblastoma cells.

Alitretinoin can effectively treat frontal fibrosing alopecia.

Blocking a specific receptor slows down hair loss in mice.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

Melatonin may treat rosacea and Alzheimer's by reducing inflammation and affecting blood vessel growth.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Annurca apple extract may help with hair growth and prevent hair loss.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

New compounds show promise as nonsteroidal treatments for hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.